Recommended pre-submission checks
Powered by 

Journal of Health Economics and Outcomes Research Journal Specifications
Indexed in the following public directories
Web of Science
DOAJ
SJR
| Overview | |
| Publisher | Columbia Data Analytics, LLC |
| Language | English |
| Article Processing Charges | USD 1500 |
| Publication Time | 10 |
| Editorial Review Process | Double blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Journal of Health Economics and Outcomes Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Health Economics and Outcomes Research
Systematic Literature Reviews of Health-State Utility Values, Costs, and Healthcare Resource Use in Duchenne Muscular Dystrophy
- 28 Apr 2026
- Journal of Health Economics and Outcomes Research
Epidemiology, Patient Characteristics, Real-World Treatment Patterns, and Healthcare Utilization and Spending for Patients with Multifocal Motor Neuropathy: A US Claims-Based Analysis
- 3 Apr 2026
- Journal of Health Economics and Outcomes Research
Retrospective Analysis of Burden of Illness of Congenital Pulmonary Valve Disease in a Large, Commercially Insured US Population
- 19 Mar 2026
- Journal of Health Economics and Outcomes Research
Retrospective Analysis of Burden of Illness of Congenital Pulmonary Valve Disease in a Large, Commercially Insured US Population.
- 19 Mar 2026
- Journal of health economics and outcomes research
The Fiscal Consequences for the Canadian Government of Efgartigimod in the Treatment of Generalized Myasthenia Gravis
- 11 Mar 2026
- Journal of Health Economics and Outcomes Research
The Fiscal Consequences for the Canadian Government of Efgartigimod in the Treatment of Generalized Myasthenia Gravis
- 11 Mar 2026
- Journal of Health Economics and Outcomes Research
Systematic Literature Reviews of Health-State Utility Values, Costs, and Healthcare Resource Use in Duchenne Muscular Dystrophy
- 28 Apr 2026
- Journal of Health Economics and Outcomes Research
Epidemiology, Patient Characteristics, Real-World Treatment Patterns, and Healthcare Utilization and Spending for Patients with Multifocal Motor Neuropathy: A US Claims-Based Analysis
- 3 Apr 2026
- Journal of Health Economics and Outcomes Research
Retrospective Analysis of Burden of Illness of Congenital Pulmonary Valve Disease in a Large, Commercially Insured US Population
- 19 Mar 2026
- Journal of Health Economics and Outcomes Research
Retrospective Analysis of Burden of Illness of Congenital Pulmonary Valve Disease in a Large, Commercially Insured US Population.
- 19 Mar 2026
- Journal of health economics and outcomes research
The Fiscal Consequences for the Canadian Government of Efgartigimod in the Treatment of Generalized Myasthenia Gravis
- 11 Mar 2026
- Journal of Health Economics and Outcomes Research
The Fiscal Consequences for the Canadian Government of Efgartigimod in the Treatment of Generalized Myasthenia Gravis
- 11 Mar 2026
- Journal of Health Economics and Outcomes Research